Stay updated with breaking news from Jsr Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JSR Life Sciences, LLC ("JSR") today announced that Similis Bio ("Similis"), its business unit focused on biosimilar development, has announced plans to enter into a partnership with Novel351k to co-develop
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH.
/PRNewswire/ -- The "Chromatography Resin Market by Type, Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Mixed Mode), Application...
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Chromatography Resin Market by Type, Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size...
/PRNewswire/ -- The "Chromatography Resin - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19...